Salomon Azoulay, M.D.

Salomon Azoulay, M.D.

Chief Medical OfficeratMBX Biosciences· In proxies 2023–2025

Pay in FY2025-52% from the year before · MBX Biosciences stock +71.1% the same year

Salomon Azoulay, M.D. was paid $1.5M in FY2025 (Dec), down 52%. MBX Biosciences stock rose 71.1% that year.

Pay$100 in the stock at the end of FY24 → $171
Pay is from the Summary Compensation Table of each MBX Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. MBX BiosciencesPublic company · 3 yr
    • Chief Medical Officer2023 – Present · 3 yrStock in role +129%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?